The Universal Selection Source:
Coatings Ingredients
Industry News

Bayer MaterialScience AG Invests in High-tech Products for Medical Technology

Published on 2010-03-16. Author : SpecialChem

PITTSBURGH -- Bayer MaterialScience has recently completed its acquisition of PolyBioMed Ltd. based in Sheffield, United Kingdom, thereby expanding its product portfolio for medical technology. PolyBioMed, formerly a subsidiary of Lombard Medical Technologies plc, provides polymer coatings, surface treatments and biomaterials to the medical device industry.

The acquisition gives Bayer MaterialScience access to application areas such as coronary drug-eluting stents, plus catheter systems for interventional cardiology, urology and neurology. The aim is to provide innovative materials which can enhance design, manufacturing and end-use performance for a variety of medical devices.

PolyBioMed's coatings technologies are complimentary to Bayer MaterialScience's existing polyurethane-based hydrophilic coating platform, allowing it to offer an extended portfolio of permanent and biodegradable surface modification techniques.

Dr. Hans-Wilhelm Engels, senior vice president, Coatings, Adhesives & Specialties, Bayer MaterialScience AG, comments: "This acquisition complements our existing portfolio of coatings technologies for the medical device industry and offers us a significant foothold in this large and growing segment. We will be investing further in coatings application and testing facilities which will significantly expand our services to customers."

Included in the intellectual property Bayer MaterialScience AG has acquired are the rights to over 75 patents and patent applications. "Acquiring PolyBioMed's coatings and surface treatment technologies will allow us to address unmet needs such as improved coatings adhesion on plastics or metal surfaces used in many medical devices," added Dr. Michael Mager, head of Medical Coatings & Adhesives, Bayer MaterialScience AG.

About Bayer MaterialScience:

Bayer MaterialScience LLC is one of the leading producers of polymers and high-performance plastics in North America and is part of the global Bayer MaterialScience business with nearly 15,100 employees at 30 sites around the world and 2008 sales of 9.7 billion euros. Business activities are focused on the manufacture of high-tech polymer materials and the development of innovative solutions for products used in many areas of daily life. The main segments served are the automotive, electrical and electronics, construction, medical, and sports and leisure industries.

Forward-Looking Statements

This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Source: Bayer MaterialScience

Omya Calcium Carboantes
Back to Top